BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

597 related articles for article (PubMed ID: 23993326)

  • 21. Impact of completeness of revascularization on the five-year outcome in percutaneous coronary intervention and coronary artery bypass graft patients (from the ARTS-II study).
    Sarno G; Garg S; Onuma Y; Gutiérrez-Chico JL; van den Brand MJ; Rensing BJ; Morel MA; Serruys PW;
    Am J Cardiol; 2010 Nov; 106(10):1369-75. PubMed ID: 21059423
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Percutaneous coronary intervention versus coronary artery bypass grafting in patients with three-vessel or left main coronary artery disease: 10-year follow-up of the multicentre randomised controlled SYNTAX trial.
    Thuijs DJFM; Kappetein AP; Serruys PW; Mohr FW; Morice MC; Mack MJ; Holmes DR; Curzen N; Davierwala P; Noack T; Milojevic M; Dawkins KD; da Costa BR; Jüni P; Head SJ;
    Lancet; 2019 Oct; 394(10206):1325-1334. PubMed ID: 31488373
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of the elevation of biochemical markers of myocardial damage on long-term mortality after percutaneous coronary intervention: results of the CK-MB and PCI study.
    Cavallini C; Savonitto S; Violini R; Arraiz G; Plebani M; Olivari Z; Rubartelli P; Battaglia S; Niccoli L; Steffenino G; Ardissino D;
    Eur Heart J; 2005 Aug; 26(15):1494-8. PubMed ID: 15741227
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical outcomes with percutaneous coronary revascularization vs coronary artery bypass grafting surgery in patients with unprotected left main coronary artery disease: A meta-analysis of 6 randomized trials and 4,686 patients.
    Palmerini T; Serruys P; Kappetein AP; Genereux P; Riva DD; Reggiani LB; Christiansen EH; Holm NR; Thuesen L; Makikallio T; Morice MC; Ahn JM; Park SJ; Thiele H; Boudriot E; Sabatino M; Romanello M; Biondi-Zoccai G; Cavalcante R; Sabik JF; Stone GW
    Am Heart J; 2017 Aug; 190():54-63. PubMed ID: 28760214
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Global risk classification and clinical SYNTAX (synergy between percutaneous coronary intervention with TAXUS and cardiac surgery) score in patients undergoing percutaneous or surgical left main revascularization.
    Capodanno D; Caggegi A; Miano M; Cincotta G; Dipasqua F; Giacchi G; Capranzano P; Ussia G; Di Salvo ME; La Manna A; Tamburino C
    JACC Cardiovasc Interv; 2011 Mar; 4(3):287-97. PubMed ID: 21435606
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of baseline C-reactive protein levels with periprocedural myocardial injury in patients undergoing percutaneous bifurcation intervention: a CACTUS study subanalysis.
    Niccoli G; Sgueglia GA; Latib A; Crea F; Colombo A;
    Catheter Cardiovasc Interv; 2014 Jan; 83(1):E37-44. PubMed ID: 23813627
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of large periprocedural myocardial infarction on mortality after percutaneous coronary intervention and coronary artery bypass grafting for left main disease: an analysis from the EXCEL trial.
    Ben-Yehuda O; Chen S; Redfors B; McAndrew T; Crowley A; Kosmidou I; Kandzari DE; Puskas JD; Morice MC; Taggart DP; Leon MB; Lembo NJ; Brown WM; Simonton CA; Dressler O; Kappetein AP; Sabik JF; Serruys PW; Stone GW
    Eur Heart J; 2019 Jun; 40(24):1930-1941. PubMed ID: 30919909
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Troponin T is a better predictor than creatine kinase-MB of long-term mortality after coronary artery bypass graft surgery.
    Søraas CL; Friis C; Engebretsen KV; Sandvik L; Kjeldsen SE; Tønnessen T
    Am Heart J; 2012 Nov; 164(5):779-85. PubMed ID: 23137510
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Individual Long-Term Mortality Prediction Following Either Coronary Stenting or Bypass Surgery in Patients With Multivessel and/or Unprotected Left Main Disease: An External Validation of the SYNTAX Score II Model in the 1,480 Patients of the BEST and PRECOMBAT Randomized Controlled Trials.
    Sotomi Y; Cavalcante R; van Klaveren D; Ahn JM; Lee CW; de Winter RJ; Wykrzykowska JJ; Onuma Y; Steyerberg EW; Park SJ; Serruys PW
    JACC Cardiovasc Interv; 2016 Aug; 9(15):1564-72. PubMed ID: 27491605
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association between CK-MB elevation after percutaneous or surgical revascularization and three-year mortality.
    Brener SJ; Lytle BW; Schneider JP; Ellis SG; Topol EJ
    J Am Coll Cardiol; 2002 Dec; 40(11):1961-7. PubMed ID: 12475456
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relation of troponin I levels following nonemergent percutaneous coronary intervention to short- and long-term outcomes.
    Feldman DN; Minutello RM; Bergman G; Moussa I; Wong SC
    Am J Cardiol; 2009 Nov; 104(9):1210-5. PubMed ID: 19840564
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Outcomes in patients with de novo left main disease treated with either percutaneous coronary intervention using paclitaxel-eluting stents or coronary artery bypass graft treatment in the Synergy Between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery (SYNTAX) trial.
    Morice MC; Serruys PW; Kappetein AP; Feldman TE; Ståhle E; Colombo A; Mack MJ; Holmes DR; Torracca L; van Es GA; Leadley K; Dawkins KD; Mohr F
    Circulation; 2010 Jun; 121(24):2645-53. PubMed ID: 20530001
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The negative impact of incomplete angiographic revascularization on clinical outcomes and its association with total occlusions: the SYNTAX (Synergy Between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery) trial.
    Farooq V; Serruys PW; Garcia-Garcia HM; Zhang Y; Bourantas CV; Holmes DR; Mack M; Feldman T; Morice MC; Ståhle E; James S; Colombo A; Diletti R; Papafaklis MI; de Vries T; Morel MA; van Es GA; Mohr FW; Dawkins KD; Kappetein AP; Sianos G; Boersma E
    J Am Coll Cardiol; 2013 Jan; 61(3):282-94. PubMed ID: 23265332
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SYNTAX Score is associated with worse outcomes after off-pump coronary artery bypass grafting surgery for three-vessel or left main complex coronary disease.
    Carnero-Alcázar M; Maroto Castellanos LC; Silva Guisasola JA; Cobiella Carnicer J; Alswies A; Fuentes Ferrer ME; Rodríguez Hernández JE
    J Thorac Cardiovasc Surg; 2011 Sep; 142(3):e123-32. PubMed ID: 21269648
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Three-year outcomes after percutaneous coronary intervention and coronary artery bypass grafting in patients with heart failure: from the CREDO-Kyoto percutaneous coronary intervention/coronary artery bypass graft registry cohort-2†.
    Marui A; Kimura T; Nishiwaki N; Komiya T; Hanyu M; Shiomi H; Tanaka S; Sakata R;
    Eur J Cardiothorac Surg; 2015 Feb; 47(2):316-21; discussion 321. PubMed ID: 24662243
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predictive accuracy of SYNTAX score for predicting long-term outcomes of unprotected left main coronary artery revascularization.
    Chakravarty T; Buch MH; Naik H; White AJ; Doctor N; Schapira J; Mirocha JM; Fontana G; Forrester JS; Makkar R
    Am J Cardiol; 2011 Feb; 107(3):360-6. PubMed ID: 21256999
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early and long-term outcomes after surgical and percutaneous myocardial revascularization in patients with non-ST-elevation acute coronary syndromes and unprotected left main disease.
    Buszman PP; Bochenek A; Konkolewska M; Trela B; Kiesz RS; Wilczyński M; Cisowski M; Krejca M; Banasiewicz-Szkróbka I; Krol M; Kondys M; Wiernek S; Orlik B; Martin JL; Tendera M; Buszman PE
    J Invasive Cardiol; 2009 Nov; 21(11):564-9. PubMed ID: 19901409
    [TBL] [Abstract][Full Text] [Related]  

  • 38. One-stop hybrid coronary revascularization versus coronary artery bypass grafting and percutaneous coronary intervention for the treatment of multivessel coronary artery disease: 3-year follow-up results from a single institution.
    Shen L; Hu S; Wang H; Xiong H; Zheng Z; Li L; Xu B; Yan H; Gao R
    J Am Coll Cardiol; 2013 Jun; 61(25):2525-33. PubMed ID: 23623906
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mortality after coronary artery bypass grafting versus percutaneous coronary intervention with stenting for coronary artery disease: a pooled analysis of individual patient data.
    Head SJ; Milojevic M; Daemen J; Ahn JM; Boersma E; Christiansen EH; Domanski MJ; Farkouh ME; Flather M; Fuster V; Hlatky MA; Holm NR; Hueb WA; Kamalesh M; Kim YH; Mäkikallio T; Mohr FW; Papageorgiou G; Park SJ; Rodriguez AE; Sabik JF; Stables RH; Stone GW; Serruys PW; Kappetein AP
    Lancet; 2018 Mar; 391(10124):939-948. PubMed ID: 29478841
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prediction of 1-year mortality in patients with acute coronary syndromes undergoing percutaneous coronary intervention: validation of the logistic clinical SYNTAX (Synergy Between Percutaneous Coronary Interventions With Taxus and Cardiac Surgery) score.
    Farooq V; Vergouwe Y; Généreux P; Bourantas CV; Palmerini T; Caixeta A; Garcìa-Garcìa HM; Diletti R; Morel MA; McAndrew TC; Kappetein AP; Valgimigli M; Windecker S; Dawkins KD; Steyerberg EW; Serruys PW; Stone GW
    JACC Cardiovasc Interv; 2013 Jul; 6(7):737-45. PubMed ID: 23866185
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.